NASDAQ: VVOS - Vivos Therapeutics, Inc.

Rentabilität für sechs Monate: +19.16%
Dividendenrendite: 0.00%
Sektor: Healthcare

Aktionsplan Vivos Therapeutics, Inc.

Erweiterter Zeitplan Einfaches Diagramm
Financial Markets by TradingView

Über das Unternehmen Vivos Therapeutics, Inc.

Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children.

weitere details
It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. The company was founded in 2016 and is based in Littleton, Colorado.
Zur Vergleichsliste hinzufügen
Auf die Beobachtungsliste
Zum Portfolio hinzufügen
Preishinweis hinzufügen

IPO date 2020-12-11
ISIN US92859E1082
Industry Health Care Equipment & Supplies
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://vivos.com
Цена ао 3.2
Preisänderung pro Tag: -2.51% (3.19)
Preisänderung pro Woche: -13.61% (3.6)
Preisänderung pro Monat: -9.86% (3.45)
Preisänderung über 3 Monate: -33.12% (4.65)
Preisänderung über sechs Monate: +19.16% (2.61)
Preisänderung pro Jahr: -35.61% (4.83)
Preisänderung über 3 Jahre: +21.96% (2.55)
Preisänderung seit Jahresbeginn: -35.34% (4.81)
Alle Parameter

Unterschätzung

Name Bedeutung Grad
P/S 0.379 10
P/BV 12.73 1
P/E 0 0
EV/EBITDA -0.3348 0
Gesamt: 5.13

Effizienz

Name Bedeutung Grad
ROA, % -126.59 0
ROE, % -3304.87 0
Gesamt: 0

Dividenden

Name Bedeutung Grad
Div yield, % 0 0
DSI 0 0
Gesamt: 0

Pflicht

Name Bedeutung Grad
Debt/EBITDA -0.1196 10
Gesamt: 10

Wachstumsimpuls

Name Bedeutung Grad
Rentabilität Revenue, % 5.35 1
Rentabilität Ebitda, % 48.88 6
Rentabilität EPS, % 1524.75 10
Gesamt: 6.8
Weitere Details

Institutionen Volumen Aktie, %
Strategic Wealth Investment Group, LLC 128789 9.67
Vanguard Group Inc 24601 1.85
Geode Capital Management, LLC 8078 0.61
Blue Trust, Inc. 4000 0.3
Credit Agricole S.A. 2364 0.18
State Street Corporation 1826 0.14
LPL Financial LLC 1419 0.11
Northern Trust Corporation 1186 0.09
HighTower Advisors, LLC 746 0.06
SignatureFD, LLC 547 0.04



Aufsicht Berufsbezeichnung Zahlung Geburtsjahr
Mr. R. Kirk Huntsman Co-Founder, Chairman of the Board & CEO 482.16k 1958 (67 Jahre)
Mr. Bradford K. Amman CFO, Treasurer & Secretary 335.53k 1962 (63 Jahr)
Mr. Todd Huntsman Co-Founder & Senior VP of Product and Technology N/A
Ms. RaeAnn Byrnes Co-Founder and Senior VP of Events & Clinical Advisory Services N/A
Ms. Susan McCullough Co-Founder & Executive VP of Operations N/A
Mr. Nicholas M. DeGennaro Senior Vice President of Medical Integration Division N/A
Ms. Ruth Hembree Senior Vice President of Practice Services N/A
Ms. Stephanie Huebner Senior Vice President of Dental Service Integration N/A
Mr. John Ballard Senior Vice President of Technology N/A

Adresse: United States, Littleton. CO, 7921 Southpark Plaza - in Google Maps öffnen, Öffnen Sie Yandex-Karten
Webseite: https://vivos.com